Botulinum toxin injection into the bilateral external oblique muscle to treat camptocormia in Parkinson's disease

Botulinum toxin injection into the bilateral external oblique muscle to treat camptocormia in Parkinson's disease - Botulinum therapy to treat camptocormia in Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220371

Enrollment

Registered

2018-07-31

Start date

2016-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Camptocormia in Parkinson's disease

Interventions

Intervention type:PROCEDURE Name of intervention:open labelled imtramuscular injection Dose form / Japanese Medical Device Nomenclature:INJECTION Route of administration / Site of application:INTRAMUS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult-onset Parkinson's disease, with bothering symptoms thoracic-level camptocormia

Exclusion criteria

Exclusion criteria: dementia, severe systemic disease, allergy for botulinum toxin

Design outcomes

Primary

Measure	Time frame
Patients' complaint and abnormality in physical examination associated with camptocormia and the angle of spinal bending	—

Countries

Japan

Contacts

Public ContactHiroyuki Todo

National Health Organization Hyogo-Chuo National Hospital

mailbox@hch.hosp.go.jp+81-79-563-2121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026